Stock Analysis
- United States
- /
- Life Sciences
- /
- NYSE:TMO
Thermo Fisher Scientific Third Quarter 2024 Earnings: EPS Beats Expectations
Thermo Fisher Scientific (NYSE:TMO) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$10.6b (flat on 3Q 2023).
- Net income: US$1.63b (down 5.0% from 3Q 2023).
- Profit margin: 15% (in line with 3Q 2023).
- EPS: US$4.27 (down from US$4.44 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Thermo Fisher Scientific EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 9.0%.
Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Life Sciences industry in the US.
Performance of the American Life Sciences industry.
The company's shares are down 2.5% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 2 warning signs for Thermo Fisher Scientific you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Thermo Fisher Scientific might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:TMO
Thermo Fisher Scientific
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.